共 8 条
[2]
Memantine Treatment in Mild to Moderate Alzheimer Disease: A 24-Week Randomized, Controlled Trial[J] . Elaine R. Peskind,Steven G. Potkin,Nunzio Pomara,Brian R. Ott,Stephen M. Graham,Jason T. Olin,Scott McDonald.American Journal of Geriatric Psychiatry . 2006 (8)
[3]
Efficacy and Safety of Memantine in Moderate-to-Severe Alzheimer Disease: The Evidence to Date[J] . Roger Bullock.Alzheimer Disease & Associated Disorders . 2006 (1)
[5]
Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions[J] . Stanislav Micuda,Lucie Mundlova,Eva Anzenbacherova,Pavel Anzenbacher,Jaroslav Chladek,Leos Fuksa,Jirina Martinkova.European Journal of Clinical Pharmacology . 2004 (8)
[7]
Influence of the N -methyl- d -aspartate antagonist memantine on human motor cortex excitability[J] . Peter Schwenkreis,Katja Witscher,Frank Janssen,Adjoa Addo,Roman Dertwinkel,Michael Zenz,Jean-Pierre Malin,Martin Tegenthoff.Neuroscience Letters . 1999 (3)
[8]
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Tariot PN,Farlow MR,Grossberg GT, et al. The Journal of The American Medical Association . 2004